Literature DB >> 16984533

Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagus.

R Dickman1, J L Kim, L Camargo, S B Green, R E Sampliner, H S Garewal, R Fass.   

Abstract

Thus far, there has been a paucity of studies that have assessed the value of the different gastroesophageal reflux disease (GERD) symptom characteristics in identifying patients with long-segment Barrett's esophagus versus those with short-segment Barrett's esophagus. To determine if any of the symptom characteristics of GERD correlates with long-segment Barrett's esophagus versus short-segment Barrett's esophagus. Patients seen in our Barrett's clinic were prospectively approached and recruited into the study. All patients underwent an endoscopy, validated GERD symptoms questionnaire and a personal interview. Of the 88 Barrett's esophagus patients enrolled into the study, 47 had short-segment Barrett's esophagus and 41 long-segment Barrett's esophagus. Patients with short-segment Barrett's esophagus reported significantly more daily heartburn symptoms (84.1%) than patients with long-segment Barrett's esophagus (63.2%, P = 0.02). There was a significant difference in reports of severe to very severe dysphagia in patients with long-segment Barrett's esophagus versus those with short-segment Barrett's esophagus (76.9%vs. 38.1%, P = 0.02). Longer duration in years of chest pain was the only symptom characteristic of gastroesophageal reflux disease associated with longer lengths of Barrett's mucosa. Reports of severe or very severe dysphagia were more common in long-segment Barrett's esophagus patients. Only longer duration of chest pain was correlated with longer lengths of Barrett's esophagus.

Entities:  

Mesh:

Year:  2006        PMID: 16984533     DOI: 10.1111/j.1442-2050.2006.00606.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  4 in total

1.  Scintigraphy in laryngopharyngeal and gastroesophageal reflux disease: a definitive diagnostic test?

Authors:  Gregory L Falk; John Beattie; Alvin Ing; S E Falk; Michael Magee; Leticia Burton; Hans Van der Wall
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?

Authors:  Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

3.  Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy.

Authors:  Giovanni Zaninotto; Paola Parente; Renato Salvador; Fabio Farinati; Chiara Tieppo; Nicola Passuello; Lisa Zanatta; Matteo Fassan; Francesco Cavallin; Mario Costantini; Claudia Mescoli; Giorgio Battaglia; Alberto Ruol; Ermanno Ancona; Massimo Rugge
Journal:  J Gastrointest Surg       Date:  2011-11-16       Impact factor: 3.452

4.  Fundoplication for laryngopharyngeal reflux despite preoperative dysphagia.

Authors:  G L Falk; H Van der Wall; L Burton; M G Falk; H O'Donnell; S J Vivian
Journal:  Ann R Coll Surg Engl       Date:  2017-02-13       Impact factor: 1.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.